Quick Answer
Zhengye Biotechnology Holding Ltd reported Research And Development Expense of $1.75 million for the year ending 2024.
- Zhengye Biotechnology Holding Ltd showed a decrease of -85.3% in Research And Development Expense from 2023 to 2024.
- This data is from Zhengye Biotechnology Holding Ltd's annual report (Form 10-K), filed with the SEC on July 3, 2025.
- XBRL data for this metric is available from 2022 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2022 to 2024), Zhengye Biotechnology Holding Ltd's Research And Development Expense has declined by 86.9%.
- Historical annual values: Fiscal year 2024: $1.75 million | Fiscal year 2023: $11.90 million | Fiscal year 2022: $13.42 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: